Moonlake Immunotherapeutics (MLTX) — DEF 14A Filings
All DEF 14A filings from Moonlake Immunotherapeutics. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
MoonLake Immunotherapeutics Files Definitive Proxy Statement
— Apr 22, 2025 Risk: low
MoonLake Immunotherapeutics filed a definitive proxy statement (DEF 14A) on April 22, 2025, for its annual meeting on June 5, 2025. The company, formerly known -
MoonLake Immunotherapeutics Announces 2024 Annual General Meeting of Shareholders
— Apr 24, 2024 Risk: low
MoonLake Immunotherapeutics (MLTX) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. The 2024 Annual General Meeting of Shareholders for MoonLak
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX